Survival of Serratia marcescens in the Presence of Complement

References

• Salceda SR, Lapuz J, Vizconde R. Serratia marcescens en en-dophthalmitis. Arch Ophthalmol 1973; 89: 163�6.
   Google Scholar
• Atlee WE, Burns RP, Oden M. Serratia marcescens kerato-conjunctivitis. Am J Ophthalmol 1970; 70: 31–3.
   Google Scholar
• Levine M, Serdarevic 0, Mahar M, Chen S. Microbial trends and � uoroquinolone resistance in contact lens related microbial keratitis. Invest Ophthalmol Vis Sci 1996; 37: s876.
   Google Scholar
• Holden BA, La Hood D, Grant T, Newton-Howes J, Baleriola-Lucas C, Willcox MDP, Sweeney DF. Gram-negative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J 1996; 22: 47�52.
   Google Scholar
• Hume EBH, Willcox MDP, Sweeney DF, Holden BA. An examination of clonal variants of Serratia marcescens that infect the eye during contact lens wear. J Med Micro 1996; 45: 127–32.
   Web of Science ®Google Scholar
• Simberkoff MS, Ricupero I, Rahal JJ Jr. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes. J Lab Clin Med 1976; 87: 206�17.
   Google Scholar
• Cowell B, Willcox MDP, Schneider R. Growth of gram negative bacteria in a simulated ocular environment. Aust NZ J Ophthalmol 1996; 25: s23–6.
   Google Scholar
• Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Oph-thalmol Vis Sci 1992; 33: 626–39.
   PubMed Web of Science ®Google Scholar
• Willcox MDP, Morris CA, Thakur A, Sack RA, Wickson J, Boey W. Complement and complement regulatory proteins in human tears. Invest Ophthalmol Vis Sci 1997; 38: 1–8.
   PubMed Web of Science ®Google Scholar
• Frank MM, Fries LF. The role of complement in inflamma-tion and phagocytosis. Immunol Today 1991; 12: 322–6.
   PubMedGoogle Scholar
• Johnson MK, Callegan MC, Engle LS, O'Calleghan RJ, Hill JM, Hobden JA, Boulnois GJ, Andrew PW, Mitchell TJ. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. Curr Eye Res 1995; 14: 281–4.
   Google Scholar
• Hazlett LD, Masinick-McCellan SA, Barrett RP. Comple-ment defects in aged mice compromise phagocytosis of Pseu- domonas aeruginosa. Curr Eye Res 1999; 19: 26�32.
   Web of Science ®Google Scholar
• Gordon DL, Rice J, Finlay-Jones JJ, McDonald PJ, Hostetter MK. Analysis of C3 deposition and degradation on bacterial surfaces after opsonisation. J Infect Dis 1988; 157: 697–704.
   Google Scholar
• Slot JW, Geuze HJ. A new method of preparing gold probes for multiple-labelling cytochemistry. Eur J Cell Biol 1985; 38: 87–93.
   PubMed Web of Science ®Google Scholar
• Roth J. The protein A-gold (pAg) technique: a qualitative and quantitative approach for antigen localisation on thin sections. In: Bullock GR, Petrusz P, eds Techniques in Immuno-cytochemistry, vol. 1. London: Academic Press, 1982: 107–33.
   Google Scholar
• Roth J. The colloidal gold marker system for light and electron microscopic cytochemistry. In: Bullock GR, Petrusz P, eds Techniques in Immunocytochemistry, vol. 2. London: Academic Press, 1983: 216–84.
   Google Scholar
• Morris CA, Underwood PA, Bean PA, Sheehan M, Charlsworth JA. Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies. J Biol Chem 1994; 269: 23845–3852.
   Google Scholar
• Westphal O, Jann K Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. In: Whistler RL, Wolfron ML, eds Methods in Carbohydrate Chemistry, vol. 5. New York: Academic Press, 1965: 83–91.
   Google Scholar
• Loos M. The complement system: activation and control. Curr Top Microbiol Immunol 1985; 121: 7–17.
   Web of Science ®Google Scholar
• Dahlba�ck B, Podack ER. Characterisation of human S protein, an inhibitor of the membrane attack complex of complement Demonstration of a free reactive thiol group. Biochemistry 1985; 24: 2368–74.
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Jeurissen SHM. Modulation of classical C3 con-vertase of complement by tear lactoferrin. Immunology 1982; 47: 263–70.
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Jeurissen SHM, Koning KM. Lactoferrin levels in normal human tears. Br J Ophthalmol 1983; 67: 199–202.
   PubMed Web of Science ®Google Scholar
• Sack RA, Underwood PA, Tan KO, Sutherland H, Morris CA. Vitronectin. Possible contribution to the closed-eye external host-defence mechanism. Ocular Immunol Inflam 1993; 1: 327–36.
   Google Scholar
• Sitaramamma T, Willcox MDP, Sack RA, Shivaji S, Morris CA. Homeostatic mechanisms that operate in the tear film during eye closure-identification of tear borne complement regulators. In: Husband AJ, Cripps A W, Beagley KW, eds Mucosal Solutions: Advances in Mucosal Immunology, vol. 1. Sydney: University of Sydney, 1998: 337–46.
   Google Scholar
• Carbonell GV, Levy CE, Vidotto MC. Serratia marcescens: studies on normal human serum resistance, serogrouping and pathogenicity for mice. Rev Microbiol 1992; 23: 72–5.
   Google Scholar
• Traub WH, Kleber I. Selective activation of classical and alternative pathways of human complement by 'promptly serum-sensitive' and 'delayed serum-sensitive' strains of Serratia marcescens. Infect Immun 1976; 13: 1343–6.
   Web of Science ®Google Scholar
• Palomar J, Montilla R, Fuste� MC, Vin�as M. The role of O-antigen in susceptibility of Serratia marcescens to non-immune serum. Microbios 1993; 76: 189–96.
   Google Scholar
• Wilson ME, Morrison DC. Evidence for different requirements in physical state for the interaction of lipopolysaccha-rides with the classical and alternative pathways of complement Eur J Biochem 1982; 128: 137–41.
   Google Scholar
• Pilz D, Vocke T, Heesemann J, Brade V. Mechanism of Yad A-mediated serum resistance of Yersinia enterolitica serotype O3. Infect Immun 1992; 60: 89–195.
   Web of Science ®Google Scholar
• Hortsmann RD, Sievertsen HJ, Knobloch J, Fischetti VA. Antiphagocytic activity of Streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 1988; 85: 1657–61.
   Web of Science ®Google Scholar
• Goldman RC, Joiner K, Leive L. Serum-resistant mutants of Escherichia coli 0111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen. J Bacteriol 1984; 159: 877–82.
   Google Scholar
• Jessop HL, Lambert PA. The role of surface polysaccharide in determining the resistance of Serratia marcescens to serum killing. J Gen Microbiol 1986; 132: 2505–14.
   Google Scholar